Carolina Reduzzi

1.5k total citations
56 papers, 630 citations indexed

About

Carolina Reduzzi is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carolina Reduzzi has authored 56 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Cancer Research, 43 papers in Oncology and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carolina Reduzzi's work include Cancer Genomics and Diagnostics (47 papers), Cancer Cells and Metastasis (33 papers) and Advanced Breast Cancer Therapies (9 papers). Carolina Reduzzi is often cited by papers focused on Cancer Genomics and Diagnostics (47 papers), Cancer Cells and Metastasis (33 papers) and Advanced Breast Cancer Therapies (9 papers). Carolina Reduzzi collaborates with scholars based in Italy, United States and Ukraine. Carolina Reduzzi's co-authors include Vera Cappelletti, Maria Grazia Daidone, Huiping Liu, Isabel Romero‐Calvo, Rokana Taftaf, Emma J. Schuster, Massimo Cristofanilli, Lorenzo Gerratana, Serena Di Cosimo and Marta Vismara and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Carolina Reduzzi

52 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carolina Reduzzi Italy 14 434 366 200 165 81 56 630
Giulia Gallerani Italy 12 421 1.0× 331 0.9× 241 1.2× 123 0.7× 119 1.5× 27 663
Amber Anderson United States 8 515 1.2× 385 1.1× 147 0.7× 166 1.0× 40 0.5× 8 618
Marco Petronio France 4 407 0.9× 313 0.9× 166 0.8× 113 0.7× 41 0.5× 5 567
Steve Gross United States 8 541 1.2× 348 1.0× 171 0.9× 255 1.5× 138 1.7× 14 733
Marianne Oulhen France 13 560 1.3× 501 1.4× 205 1.0× 365 2.2× 84 1.0× 20 756
Nadège Vimond France 11 439 1.0× 265 0.7× 185 0.9× 140 0.8× 123 1.5× 14 698
Anne Renolen Norway 9 385 0.9× 252 0.7× 110 0.6× 98 0.6× 49 0.6× 13 468
Fanny Billiot France 10 554 1.3× 435 1.2× 193 1.0× 280 1.7× 153 1.9× 11 735
Petra van der Spoel Netherlands 7 425 1.0× 326 0.9× 110 0.6× 140 0.8× 92 1.1× 10 528
Jake Lichterman United States 7 287 0.7× 377 1.0× 415 2.1× 142 0.9× 119 1.5× 10 739

Countries citing papers authored by Carolina Reduzzi

Since Specialization
Citations

This map shows the geographic impact of Carolina Reduzzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carolina Reduzzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carolina Reduzzi more than expected).

Fields of papers citing papers by Carolina Reduzzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carolina Reduzzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carolina Reduzzi. The network helps show where Carolina Reduzzi may publish in the future.

Co-authorship network of co-authors of Carolina Reduzzi

This figure shows the co-authorship network connecting the top 25 collaborators of Carolina Reduzzi. A scholar is included among the top collaborators of Carolina Reduzzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carolina Reduzzi. Carolina Reduzzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Davis, Andrew A., Ian S. Hagemann, Amir Behdad, et al.. (2025). Molecular Characterization of Patients with Metastatic Invasive Lobular Carcinoma: Using Real-World Data to Describe This Unique Clinical Entity. Clinical Cancer Research. 31(21). 4485–4494.
2.
Scholten, David, Lamiaa El-Shennawy, Yuzhi Jia, et al.. (2025). Double-positive T cells form heterotypic clusters with circulating tumor cells to foster cancer metastasis. Journal of Clinical Investigation. 135(18). 1 indexed citations
3.
Borea, Roberto, Eleonora Nicolò, Diego de Miguel‐Pérez, et al.. (2025). Cancer in a drop: Advances in liquid biopsy in 2024. Critical Reviews in Oncology/Hematology. 213. 104776–104776. 6 indexed citations
4.
Reduzzi, Carolina, Eleonora Nicolò, Konstantinos Venetis, et al.. (2024). Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors. Critical Reviews in Oncology/Hematology. 203. 104483–104483. 8 indexed citations
5.
Gerratana, Lorenzo, Andrew A. Davis, Paolo D’Amico, et al.. (2024). Early Evaluation of Risk Stratification and Clinical Outcomes for Patients with Advanced Breast Cancer through Combined Monitoring of Baseline Circulating Tumor Cells and DNA. Clinical Cancer Research. 30(16). 3470–3480. 2 indexed citations
6.
Cosimo, Serena Di, Marco Silvestri, Cinzia De Marco, et al.. (2024). Low-pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple-negative breast cancer. Scientific Reports. 14(1). 20479–20479. 4 indexed citations
7.
Gerratana, Lorenzo, Andrew A. Davis, Carolina Reduzzi, et al.. (2024). Integrating machine learning-predicted circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) in metastatic breast cancer: A proof of principle study on endocrine resistance profiling. Cancer Letters. 609. 217325–217325. 13 indexed citations
8.
Nicolò, Eleonora, Caterina Gianni, Eleni Andreopoulou, et al.. (2024). Circulating tumor cells et al.: towards a comprehensive liquid biopsy approach in breast cancer. PubMed. 5. 10–10. 11 indexed citations
9.
Gerratana, Lorenzo, Andrew A. Davis, Carolina Reduzzi, et al.. (2023). Cyclin-Dependent Kinase 4/6 Inhibitors Beyond Progression in Metastatic Breast Cancer: A Retrospective Real-World Biomarker Analysis. JCO Precision Oncology. 7(7). e2200531–e2200531. 7 indexed citations
10.
Nicolò, Eleonora, Elena Vagia, Paolo D’Amico, et al.. (2023). Circulating Tumor DNA and Unique Actionable Genomic Alterations in the Longitudinal Monitoring of Metastatic Breast Cancer: A Case of FGFR2-KIAA1598 Gene Fusion. JCO Precision Oncology. 7(7). e2200702–e2200702. 2 indexed citations
11.
Gerratana, Lorenzo, Katherine Clifton, Arielle J. Medford, et al.. (2023). Genetic Alterations Detected by Circulating Tumor DNA in HER2-Low Metastatic Breast Cancer. Clinical Cancer Research. 29(16). 3092–3100. 4 indexed citations
12.
Gerratana, Lorenzo, Andrew A. Davis, Katherine Clifton, et al.. (2023). Interplay between ESR1/PIK3CA codon variants, oncogenic pathway alterations and clinical phenotype in patients with metastatic breast cancer (MBC): comprehensive circulating tumor DNA (ctDNA) analysis. Breast Cancer Research. 25(1). 112–112. 7 indexed citations
13.
Reduzzi, Carolina, Lorenzo Gerratana, Youbin Zhang, et al.. (2023). Abstract P2-26-06: Association between CK+/CD45+ circulating tumor cells (CTCs) and circulating tumor DNA (ctDNA) alterations in advanced breast cancer patients. Cancer Research. 83(5_Supplement). P2–26. 1 indexed citations
14.
Nicolò, Eleonora, et al.. (2023). Real-time assessment of HER2 status in circulating tumor cells of breast cancer patients: Methods of detection and clinical implications. SHILAP Revista de lepidopterología. 2. 100117–100117. 16 indexed citations
15.
Nagara, Majdi, et al.. (2022). FOXP3+/CD68+ ratio within the tumor microenvironment may serve as a potential prognostic factor in classical Hodgkin lymphoma. Human Immunology. 83(12). 843–856. 1 indexed citations
16.
D’Amico, Paolo, Carla Corvaja, Lorenzo Gerratana, et al.. (2021). The use of liquid biopsy in early breast cancer: clinical evidence and future perspectives. Journal of Cancer Metastasis and Treatment. 2021. 17 indexed citations
17.
Ferraris, Cristina, Chiara Listorti, Vera Cappelletti, et al.. (2020). Red clover and lifestyle changes to contrast menopausal symptoms in premenopausal patients with hormone-sensitive breast cancer receiving tamoxifen. Breast Cancer Research and Treatment. 180(1). 157–165. 11 indexed citations
18.
Vismara, Marta, Carolina Reduzzi, Maria Grazia Daidone, & Vera Cappelletti. (2020). Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs. Advances in experimental medicine and biology. 1220. 81–91. 5 indexed citations
19.
Reduzzi, Carolina, Marta Vismara, Lorenzo Gerratana, et al.. (2019). The curious phenomenon of dual-positive circulating cells: Longtime overlooked tumor cells. Seminars in Cancer Biology. 60. 344–350. 32 indexed citations
20.
Reduzzi, Carolina, Giulia Bertolini, Patrizia Miodini, et al.. (2017). Development of a Protocol for Single-Cell Analysis of Circulating Tumor Cells in Patients with Solid Tumors. Advances in experimental medicine and biology. 994. 83–103. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026